Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-030385
Filing Date
2025-03-03
Accepted
2025-03-03 06:30:26
Documents
114
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K apge-20241231.htm   iXBRL 10-K 3113622
2 EX-4.3 apge-ex4_3.htm EX-4.3 42536
3 EX-19 apge-ex19.htm EX-19 128918
4 EX-21.1 apge-ex21_1.htm EX-21.1 3634
5 EX-23.1 apge-ex23_1.htm EX-23.1 4860
6 EX-31.1 apge-ex31_1.htm EX-31.1 16546
7 EX-31.2 apge-ex31_2.htm EX-31.2 16567
8 EX-32.1 apge-ex32_1.htm EX-32.1 13304
9 GRAPHIC img63888831_0.jpg GRAPHIC 110091
10 GRAPHIC img63888831_1.jpg GRAPHIC 120094
11 GRAPHIC img63888831_2.jpg GRAPHIC 102710
12 GRAPHIC img63888831_3.jpg GRAPHIC 127726
13 GRAPHIC img63888831_4.jpg GRAPHIC 77030
14 GRAPHIC img63888831_5.jpg GRAPHIC 57145
15 GRAPHIC img63888831_6.jpg GRAPHIC 100110
16 GRAPHIC img63888831_7.jpg GRAPHIC 96007
17 GRAPHIC img63888831_8.jpg GRAPHIC 105075
18 GRAPHIC img63888831_9.jpg GRAPHIC 41258
19 GRAPHIC img63888831_10.jpg GRAPHIC 35387
20 GRAPHIC img63888831_11.jpg GRAPHIC 155155
21 GRAPHIC img63888831_12.jpg GRAPHIC 62010
22 GRAPHIC img63888831_13.jpg GRAPHIC 48739
23 GRAPHIC img63888831_14.jpg GRAPHIC 98041
24 GRAPHIC img63888831_15.jpg GRAPHIC 41485
25 GRAPHIC img63888831_16.jpg GRAPHIC 35824
26 GRAPHIC img83659534_0.jpg GRAPHIC 33993
  Complete submission text file 0000950170-25-030385.txt   15491951

Data Files

Seq Description Document Type Size
27 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apge-20241231.xsd EX-101.SCH 1521653
117 EXTRACTED XBRL INSTANCE DOCUMENT apge-20241231_htm.xml XML 1907136
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Filer) CIK: 0001974640 (see all company filings)

EIN.: 934958665 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41740 | Film No.: 25693663
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)